655
Participants
Start Date
November 26, 2019
Primary Completion Date
May 8, 2024
Study Completion Date
December 1, 2026
Vutrisiran
Vutrisiran will be administered by SC injection.
Sterile Normal Saline (0.9% NaCl)
Sterile normal saline (0.9% NaCl) will be administered by SC injection.
Clinical Trial Site, New York
Clinical Trial Site, Manhasset
Clinical Trial Site, Philadelphia
Clinical Trial Site, Washington D.C.
Clinical Trial Site, Durham
Clinical Trial Site, Gainesville
Clinical Trial Site, Cleveland
Clinical Trial Site, Rochester
Clinical Trial Site, Evanston
Clinical Trial Site, Houston
Clinical Trial Site, Stanford
Clinical Trial Site, Boston
Clinical Trial Site, Boston
Clinical Trial Site, Buenos Aires
Clinical Trial Site, Adelaide
Clinical Trial Site, Melbourne
Clinical Trial Site, Sydney
Clinical Trial Site, Westmead
Clinical Trial Site, Woolloongabba
Clinical Trial Site, Vienna
Clinical Trial Site, Anderlecht
Clinical Trial Site, Dendermonde
Clinical Trial Site, Ghent
Clinical Trial Site, Leuven
Clinical Trial Site, Québec
Clinical Trial Site, Toronto
Clinical Trial Site, Zagreb
Clinical Trial Site, Olomouc
Clinical Trial Site, Prague
Clinical Trial Site, Aarhus
Clinical Trial Site, Odense
Clinical Trial Site, Créteil
Clinical Trial Site, Marseille
Clinical Trial Site, Paris
Clinical Trial Site, Toulouse
Clinical Trial Site, Essen
Clinical Trial Site, Göttingen
Clinical Trial Site, Heidelberg
Clinical Trial Site, Leipzig
Clinical Trial Site, Münster
Clinical Trial Site, Würzburg
Clinical Trial Site, Budapest
Clinical Trial Site, Dublin
Clinical Trial Site, Haifa
Clinical Trial Site, Aichi
Clinical Trial Site, Fukuoka
Clinical Trial Site, Kagawa
Clinical Trial Site, Kashihara
Clinical Trial Site, Kumamoto
Clinical Trial Site, Matsumoto
Clinical Trial Site, Nankoku
Clinical Trial Site, Osaka
Clinical Trial Site, Tokyo
Clinical Trial Site, Riga
Clinical Trial Site, Kaunas
Clinical Trial Site, Groningen
Clinical Trial Site, Utrecht
Clinical Trial Site, Oslo
Clinical Trial Site, Lima
Clinical Trial Site, San Miguel
Clinical Trial Site, Gdansk
Clinical Trial Site, Wroclaw
Clinical Trial Site, Guimarães
Clinical Trial Site, Lisbon
Clinical Trial Site, Porto
Clinical Trial Site, Seoul
Clinical Trial Site, Barcelona
Clinical Trial Site, Bilbao
Clinical Trial Site, Huelva
Clinical Trial Site, Madrid
Clinical Trial Site, Málaga
Clinical Trial Site, Gothenburg
Clinical Trial Site, Umeå
Clinical Trial Site, Birmingham
Clinical Trial Site, Cardiff
Clinical Trial Site, Glasgow
Clinical Trial Site, London
Clinical Trial Site, Manchester
Clinical Trial Site, Middlesbrough
Lead Sponsor
Alnylam Pharmaceuticals
INDUSTRY